Comparison Chart Middle East Pharmaceutical Industries Company
Stocks
4016
SA160G51UO10
Pharmaceuticals
|
Market Closed -
Saudi Arabian S.E.
13:20:00 09/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 67.05 SAR | -0.07% |
|
+0.52% | +5.52% |
| 08-27 | Avalon Pharma Reiterated at Overweight as Aljazira Capital Notes 'Solid' Q2 Growth | MT |
| 08-20 | Avalon Pharma Renews SAR50 Million Credit Facility | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY | Generic Pharmaceuticals | -0.07% | +0.52% | +5.52% | -4.06% | - | 625M |  | |  |
Select your edition
All financial news and data tailored to specific country editions
